Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franklin L Chen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitorsFranklin L Chen, Wenle Xia, Neil L Spector
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Cell signaling modifiers in prostate cancerFranklin L Chen, Andrew J Armstrong, Daniel J George
American Journal of Physiology. Heart and Circulatory Physiology|May 17, 2005
Focal gap junction uncoupling and spontaneous ventricular ectopyDavid E Gutstein, Stephan B Danik, Steve Lewitton, et al.
Molecular Cancer Therapeutics|February 4, 2010
Resistance to ErbB2 tyrosine kinase inhibitors in breast cancer is mediated by calcium-dependent activation of RelAWenle Xia, Sarah Bacus, Intisar Husain, et al.
Journal for Immunotherapy of Cancer|September 10, 2020
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor studyClaire F Verschraegen, Guy Jerusalem, Edward F McClay, et al.
JAMA Oncology|January 4, 2019
Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor TrialRaffit Hassan, Anish Thomas, John J Nemunaitis, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitorsFranklin L Chen, Wenle Xia, Neil L Spector
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Cell signaling modifiers in prostate cancerFranklin L Chen, Andrew J Armstrong, Daniel J George
American Journal of Physiology. Heart and Circulatory Physiology|May 17, 2005
Focal gap junction uncoupling and spontaneous ventricular ectopyDavid E Gutstein, Stephan B Danik, Steve Lewitton, et al.
Molecular Cancer Therapeutics|February 4, 2010
Resistance to ErbB2 tyrosine kinase inhibitors in breast cancer is mediated by calcium-dependent activation of RelAWenle Xia, Sarah Bacus, Intisar Husain, et al.
Journal for Immunotherapy of Cancer|September 10, 2020
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor studyClaire F Verschraegen, Guy Jerusalem, Edward F McClay, et al.
JAMA Oncology|January 4, 2019
Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor TrialRaffit Hassan, Anish Thomas, John J Nemunaitis, et al.
Pageof 1